NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications
Despite major progress in mantle cell lymphoma (MCL) therapeutics, MCL remains a deadly disease with a median survival not exceeding four years. No single driver genetic lesion has been described to solely give rise to MCL. The hallmark translocation t(11;14)(q13;q32) requires additional genetic alt...
Main Authors: | Leigh Deshotels, Firas M. Safa, Nakhle S. Saba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/12/10280 |
Similar Items
-
A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas
by: Russell J.H. Ryan, et al.
Published: (2017-10-01) -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
by: avinash kumar singh, et al.
Published: (2013-02-01) -
The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas
by: Mutaz Jamal Al-Khreisat, et al.
Published: (2022-06-01) -
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
by: Lavanya Lokhande, et al.
Published: (2022-07-01) -
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma
by: Alexander D. Heini, et al.
Published: (2022-09-01)